Analyze Diet
Veterinary research communications2024; doi: 10.1007/s11259-024-10443-8

Effect of age on amplitude of circulating catecholamine’s change of healthy cyclic mares.

Abstract: Catecholamines (CATs) are neurotransmitters and allostatic hormones whose plasma concentrations are physiologically modified in various species such as human, rats, mice and donkeys, with advancing age. However, currently these mechanisms are less well elucidated in horses and more specifically in mares. The hypothesis of this study was that, as in afore mentioned species, the CATs could experience physiological changes with advancing age. The objective of this study was to evaluate the concentrations of adrenaline (A), noradrenaline (NA), dopamine (DA), and serotonin (5-HT) in mares of different ages. Blood samples were drawn from 56 non-pregnant Spanish Purebred mares belonging to four different age groups: 6 to 9 years, 10 to 12 years, 13 to 16 years and > 16 years. The concentrations of A, NA, DA, and 5-HT were determined by competition EIA-Technical 3-CAt EIA, specifically validated for horses. Mares aged > 16 years showed lower A, DA, and 5-HT but higher NA concentrations than 6-9, 10-12, and 13-16 years (p < 0.05). Mares of 13-16 years showed lower A and higher NA than 6-9 and 10-12 years (p < 0.05). A and NA (r=-0.72; p < 0.05), and NA and 5-HT (r=-0.67; p < 0.05) were negatively correlated, and A and 5-HT (r = 0.74; p < 0.05) were positively correlated. Advanced age leads to a predominance of sympathetic nervous activity and lower serotonergic activity in non-pregnant mares.
Publication Date: 2024-06-24 PubMed ID: 38913240PubMed Central: 7311877DOI: 10.1007/s11259-024-10443-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates how the age of a mare affects the levels of certain hormones and neurotransmitters, with the premise that increased age may lead to physiological changes similar to those observed in other species. It was observed that older mares demonstrated lower levels of adrenaline, dopamine, and serotonin but higher levels of noradrenaline.

Research Purpose and Hypothesis

  • The researchers set out to examine whether aging in mares could cause changes in the concentration of certain hormones and neurotransmitters known as catecholamines (CATs), much like it does in other species.
  • The hypothesis was that as mares age, their levels of adrenaline (A), noradrenaline (NA), dopamine (DA), and serotonin (5-HT) would show significant changes.

Methodology

  • The study involved the collection of blood samples from 56 non-pregnant Spanish Purebred mares divided into four different age groups (6-9 years, 10-12 years, 13-16 years, and >16 years).
  • The samples were accordingly analyzed for their concentrations of adrenaline, noradrenaline, dopamine, and serotonin using a technical procedure known as the “3-CAt EIA”. This method was chosen due to its specific validation for use in horses.

Findings

  • In line with the researchers’ hypothesis, the study found changes in adrenaline, noradrenaline, dopamine, and serotonin levels across different age groups.
  • Mares aged over 16 years showed lower levels of adrenaline, dopamine, and serotonin, yet had higher levels of noradrenaline.
  • The 13-16 year group displayed lower adrenaline levels and a higher concentration of noradrenaline in comparison to the younger age groups (6-9 and 10-12 years).
  • Statistically significant negative correlations were observed between adrenaline and noradrenaline and noradrenaline and serotonin. Adrenaline and serotonin were positively correlated.

Conclusions

  • The results suggest that, as in other organisms, aging in mares is associated with physiological changes – specifically a decrease in adrenaline, dopamine, and serotonin and an increase in noradrenaline.
  • This indicates a shift towards increased sympathetic nervous activity and reduced serotonergic activity with age.

Cite This Article

APA
Satué K, Fazio E, Velasco-Martínez MG, Fauci D, Cravana C, Medica P. (2024). Effect of age on amplitude of circulating catecholamine’s change of healthy cyclic mares. Vet Res Commun. https://doi.org/10.1007/s11259-024-10443-8

Publication

ISSN: 1573-7446
NlmUniqueID: 8100520
Country: Switzerland
Language: English

Researcher Affiliations

Satué, Katiuska
  • Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, CEU-Cardenal Herrera University, Tirant lo Blanc, 7, Alfara del Patriarca, Valencia, 46115, Spain. ksatue@uchceu.es.
Fazio, Esterina
  • Department of Veterinary Sciences, Veterinary Physiology Unit, Polo Universitario Annunziata, Via Palatucci 13, Messina, 98168, Italy.
Velasco-Martínez, María Gemma
  • Department of Animal Medicine and Surgery, Faculty of Veterinary Medicine, CEU-Cardenal Herrera University, Tirant lo Blanc, 7, Alfara del Patriarca, Valencia, 46115, Spain.
Fauci, Deborah La
  • Department of Veterinary Sciences, Veterinary Physiology Unit, Polo Universitario Annunziata, Via Palatucci 13, Messina, 98168, Italy.
Cravana, Cristina
  • Department of Veterinary Sciences, Veterinary Physiology Unit, Polo Universitario Annunziata, Via Palatucci 13, Messina, 98168, Italy.
Medica, Pietro
  • Department of Veterinary Sciences, Veterinary Physiology Unit, Polo Universitario Annunziata, Via Palatucci 13, Messina, 98168, Italy.

References

This article includes 31 references
  1. Amano A, Tsunoda M, Aigaki T, Maruyama N, Ishigami A. Age-related changes of dopamine, noradrenaline, and adrenaline in adrenal glands of mice. Geriatr Gerontol Int 13(2):490–496.
  2. Ayala I, Martos NV, Silvan G, Gutierrez-Panizo C, Clavel JG, Illera JC. Cortisol, adrenocorticotropic hormone, serotonin, adrenaline and noradrenaline serum concentrations in relation to disease and stress in the horse. Res Vet Sci 93:103–107.
    doi: 10.1016/j.rvsc.2011.05.013pubmed: 21641009google scholar: lookup
  3. Baragli P, Sgorbini M, Casini L, Ducci M, Sighieri C. Early evidence of the anticipatory response of plasma catecholamine in equine exercise. J Equine Vet Sci 31:85–88.
  4. Besognet B, Hansen BS, Daels PF. Induction of reproductive function in anestrous mares using a dopamine antagonist. Theriogenology 47(2):467–480.
    doi: 10.1016/S0093-691X(97)00005-8pubmed: 16727999google scholar: lookup
  5. Cuniberti B, Badino P, Odore R, Girardi C, Re G. Effects induced by exercise on lymphocyte β-adrenergic receptors and plasma catecholamine levels in performance horses. Res Vet Sci 92(1):116–120.
    doi: 10.1016/j.rvsc.2010.11.002pubmed: 21168179google scholar: lookup
  6. De Palo P, Maggiolino A, Ceci E, Calzaretti G, Centoducati P, Tateo A. Survey on basal blood plasma catecholamine concentrations in Martina Franca donkey (Equus asinus). Equine Vet J 50:493–497.
    doi: 10.1111/evj.12799pubmed: 29265484google scholar: lookup
  7. Esler M. The sympathetic nervous system and catecholamine release and plasma clearance in normal blood pressure control, in aging and in hypertension. Hypertension pp 55–773.
  8. Ferlazzo AM, Bruschetta G, Di Pietro P, Medica P. The influence of age on plasma serotonin levels in Thoroughbred horses. Livest Sci 147:203–207.
  9. Ferlazzo A, Cravana C, Fazio E, Medica P. The different hormonal system during exercise stress coping in horses. Vet World 13(5):847–859.
    doi: 10.14202/vetworld.2020.847-859pubmed: 32636578pmc: 7311877google scholar: lookup
  10. Fowden AL, Forhead AJ, Ousey C. Endocrine adaptations in the foal over the perinatal period. Equine Vet J 44:130–139.
  11. Giussani DA, Forhead AJ, Fowden AL. Development of cardiovascular function in the horse fetus. J Physiol 15:565:1019–1030.
  12. Goldstein DS. Catecholamines101. Clin Auton Res 20:331–352.
    doi: 10.1007/s10286-010-0065-7pubmed: 20623313pmc: 3046107google scholar: lookup
  13. Haritou SJ, Zylstra R, Ralli C, Turner S, Tortonese DJ. Seasonal changes in circadian peripheral plasma concentrations of melatonin, serotonin, dopamine and cortisol in aged horses with Cushing’s disease under natural photoperiod. J Neuroendocrinol 20:988–996.
  14. Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 15(4):371–372.
  15. Huang L, Palmieri C, Bertin F-R. Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction. Res Vet Sci 152:427–433.
    doi: 10.1016/j.rvsc.2022.08.018pubmed: 36126509google scholar: lookup
  16. James GD, Alfarano AS, van Berge-Landry HM. Differential circadian catecholamine and cortisol responses between healthy women with and without a parental history of hypertension. Am J Hum Biol 26:753–759.
    doi: 10.1002/ajhb.22586pubmed: 25043989pmc: 4211948google scholar: lookup
  17. Kim J, Jung H, Choi JY, Lee JW, Yoon M. Plasma concentration of dopamine varies depending on breed, sex, and the genotype of DRD4 in horses. J Anim Sci Technol 64(4):792–729.
    doi: 10.5187/jast.2022.e44pubmed: 35969706pmc: 9353348google scholar: lookup
  18. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in horses. Vet Sci 9(10):556.
    doi: 10.3390/vetsci9100556pubmed: 36288169pmc: 9611634google scholar: lookup
  19. Marcilla M, Muñoz A, Satué K. Longitudinal changes in serum catecholamines, dopamine, serotonin, ACTH and cortisol in pregnant Spanish mares. Res Vet Sci 115:29–33.
    doi: 10.1016/j.rvsc.2017.01.020pubmed: 28131969google scholar: lookup
  20. McKeever KH, Gordon MB. Endocrine alterations in the equine athlete. pp 793–814.
  21. Medica P, Bruschetta G, Cravana C, Ferlazzo A, Fazio E. Effect of transportation on the sympatho-adrenal system responses in horses. Res Vet Sci 125:401–404.
    doi: 10.1016/j.rvsc.2017.10.001pubmed: 29126628google scholar: lookup
  22. Medica P, Giunta RP, Bruschetta G, Ferlazzo AM. The influence of training and simulated race on horse plasma serotonin levels. J Equine Vet Sci 84:102818.
    doi: 10.1016/j.jevs.2019.102818pubmed: 31864456google scholar: lookup
  23. Melrose PA, Walker RF, Douglas RH. Dopamine in the cerebrospinal fluid of prepubertal and adult horses. Brain Behav Evol 35(2):98–106.
    doi: 10.1159/000115859pubmed: 2112971google scholar: lookup
  24. Mormède P, Andanson S, Aupérin B, Beerda B, Guémené D, Malmkvist JM, Manteca X, Manteuffel G, Prunet P, van Reenen CG, Richard S, Veissier I. Exploration of the hypothalamic–pituitary–adrenal function as a tool to evaluate animal welfare. Physiol Behav 92:317–339.
    doi: 10.1016/j.physbeh.2006.12.003pubmed: 17234221google scholar: lookup
  25. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21:498–503.
    doi: 10.1161/01.HYP.21.4.498pubmed: 8458648google scholar: lookup
  26. Nicotra A, Pierucci F, Parvez H, Senatori O. Monoamine oxidase expression during development and aging. Neurotoxicology 25:155–165.
    doi: 10.1016/S0161-813X(03)00095-0pubmed: 14697890google scholar: lookup
  27. Podolak M, Kedzierski W, Bergero D. Comparison of the blood plasma catecholamines level in thoroughbred and arabian horses during the same-intensity exercise. Pol J Vet Sci 9:71–73.
    pubmed: 16573278
  28. Satué K, Fazio E, Rubio MD, Cravana C, Medica P. Intrafollicular and systemic dopamine, noradrenaline and adrenaline concentrations in cycling mares. Anim (Basel) 10(10):1896.
  29. Satué Ambrojo K, Gardon Poggi JC, Marcilla Corzano M. Clinical aspects related to plasma serotonin in the horse. .
    doi: 10.5772/intechopen.77956google scholar: lookup
  30. Seals DR, Esler MD. Human aging and the sympathoadrenal system. J Physiol 528:407–417.
  31. Sinclair D, Purves-Tyson TD, Allen KM, Weickert CS. Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain. Psychopharmacology (Berl) 231(8):1581–1599.
    doi: 10.1007/s00213-013-3415-zpubmed: 24481565pmc: 3967083google scholar: lookup

Citations

This article has been cited 0 times.